Sort
21,453 grants matching “tuberculosis”
mHealth-assisted conditional cash transfers to improve timeliness of vaccinations
$192,472Jan Ostermann · Duke University · R21 · FY2016 · TW
Siderophore secretion by Mycobacterium tuberculosis
$192,471Michael Niederweis · University Of Alabama At Birmingham · R21 · FY2022 · AI
Macrophages, Granulomas, and Bacterial Persistence
$192,448Corrella Detweiler · University Of Colorado · R21 · FY2016 · AI
Peru ICOHRTA Network for AIDS/TB Research Training
$192,445King Kennard Holmes · University Of Washington · U2R · FY2011 · TW
ASHA HIV Health Promotion Intervention in India
$192,414Adeline M Nyamathi · University Of California Los Angeles · R34 · FY2009 · MH
Large-scale Gene Deletion in Infectious M. tuberculosis
$192,382John Lap Ho · Weill Medical Coll Of Cornell Univ · R21 · FY2006 · AI
TB detection in children using a novel stool-based GeneXpert assay
$192,373David Alland · Rbhs-New Jersey Medical School · R01 · FY2021 · AI
Molecular Genetic Analysis of Mycobacterium tuberculosis
$192,346William Robert Jacobs · Albert Einstein College Of Medicine · R01 · FY2018 · AI
First-in-class rationally designed inhibitors of the SUF-like pathway of iron-sulfur cluster biosynthesis for treating infections caused by S. aureus and other Gram-positive bacteria
$192,277Richard C Holz · Colorado School Of Mines · R21 · FY2024 · AI
ASHA HIV Health Promotion Intervention in India
$192,268Adeline M Nyamathi · University Of California Los Angeles · R34 · FY2010 · MH
Host targeted immunotherapy for TB treatment
$192,202Mercedes Gonzalez-Juarrero · Colorado State University · R21 · FY2013 · AI
GLYOXYLATE SHUNT AND PARASITISM BY MYCOBACTERIUM SPP
$192,163Cornell University Ithaca · R01 · FY2001 · AI
Pulmonary impairment after tuberculosis in Georgia: Enhancing clinical research capacity to address the intersection of non-communicablediseases and tuberculosis
$192,100Maia Kipiani · National Center For Tuberculosis And Lung Diseases Jsc(Joint Stock Company) · R21 · FY2019 · TW
Ethiopia-Emory TB Research Training Program
$192,093Henry M Blumberg · Emory University · D43 · FY2015 · TW
Ethiopia-Emory TB Research Training Program
$192,093Henry M Blumberg · Emory University · D43 · FY2014 · TW
Ethiopia-Emory TB Research Training Program
$192,093Henry M Blumberg · Emory University · D43 · FY2016 · TW
EnhAncing Research and meNtoring Skills in Tuberculosis (EARN TB)
$192,027Russell Ryan Kempker · Emory University · K24 · FY2025 · AI
Development of new M. tuberculosis MmpL3 inhibitors
$191,999Robert B Abramovitch · Michigan State University · R21 · FY2020 · AI
Defining resistance and tolerance mechanisms in hyper-susceptible mice during M. tuberculosis infection
$191,999Andrew Olive · Michigan State University · R21 · FY2020 · AI
Mechanism of action of Dapsone in Mycobacterium leprae
$191,927Charlotte Avanzi · Colorado State University · R21 · FY2023 · AI
Mechanisms of MHCII expression and CD4+ T cell activation during Chlamydia trachomatis infection
$191,907Andrew Olive · Michigan State University · R21 · FY2020 · AI
Identification of Protein-Protein Interactions and Processing Events That Traffic and Activate the Bactericidal Pore-Forming Protein Perforin-2
$191,875George Patrick Munson · University Of Miami School Of Medicine · R21 · FY2021 · AI
A Novel Model of, and Pre-clinical Therapy for, Scleroderma Lung Disease
$191,875Sergei P Atamas · University Of Maryland Baltimore · R21 · FY2012 · HL
Targeting of Interferon-induced host proteins to Legionella-containing vacuoles
$191,797Joern Coers · Duke University · R21 · FY2012 · AI
Overcoming Pyrazinamide Resistance with Pyrazinoate-Cephalosporin Conjugates
$191,744Courtney C Aldrich · University Of Minnesota · R21 · FY2021 · AI